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Abstract: Understanding transportation and deposition (TD) of aerosol particles in the human
respiratory system can help clinical treatment of lung diseases using medicines. The lung airway
diameters and the breathing capacity of human lungs normally increase with age until the age of 30.
Many studies have analyzed the particle TD in the human lung airways. However, the knowledge
of the nanoparticle TD in airways of infants and children with varying inhalation flow rates is still
limited in the literature. This study investigates nanoparticle (5 nm≤ dp ≤ 500 nm) TD in the lungs of
infants, children, and adults. The inhalation air flow rates corresponding to three ages are considered
as Qin = 3.22 L/min (infant), 8.09 L/min (Child), and Qin = 14 L/min (adult). It is found that
less particles are deposited in upper lung airways (G0–G3) than in lower airways (G12–G15) in the
lungs of all the three age groups. The results suggest that the particle deposition efficiency in lung
airways increases with the decrease of particle size due to the Brownian diffusion mechanism. About
3% of 500 nm particles are deposited in airways G12–G15 for the three age groups. As the particle
size is decreased to 5 nm, the deposition rate in G12–G15 is increased to over 95%. The present
findings can help medical therapy by individually simulating the distribution of drug-aerosol for the
patient-specific lung.
Keywords: particle transport and deposition (TD); airway reduction; drug-aerosol delivery; aging
effect; lung generations; diffusion mechanism
1. Introduction
Inhalation of aerosol particles is employed directly as a drug delivery method for the
treatment of lung diseases [1,2]. However, the effectiveness of particle deposition as a drug
delivery depends on particle size, shape, and breathing capacity [3]. Therefore, a detailed
understanding of particle deposition in the human lung airways is important for human
health to measure both the efficiency of inhaled drug therapy and the health implications
of air pollution.
Many researchers have studied nanoparticles deposition in human lung models to
investigate the diffusion mechanism [4–8]. The results revealed that the percentage of
nanoparticles deposited in the deep airways was greater than microparticles. Cheng,
et al. [9] found significant amount of particles are deposited in bifurcation areas by con-
ducting experiments of nanoparticle deposition in the nasal and oral airways. Balásházy
and Hofmann [10] studied numerically the deposition of 10-nm diameter particles in
the third and fourth generation of human lungs based on the Weibel model [11]. They
found significant effects of flow rate and particles size on the deposition efficiency. The
whole human respiratory system is made up of 23 generations (the number of divisions of
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bronchioles is called generation) of airway branches (G0–G23). Moskal and Gradoń [12]
conducted numerical simulations of the TD of 10 nm and 100 nm particles in the first
two bifurcations of a symmetric lung model. The study explained the flow pattern and
particle deposition through flow visualizations. The numerical study of the particle TD
in the third and fourth generation conducted by Hofmann, et al. [13] demonstrated that
in the range of 1 nm ≤ dp ≤ 500 nm, more small size nanoparticles is deposited in the
lung airways than large size nanoparticles. CFD simulations of a realistic lung model
from generations G0 to G6 were performed by Pourmehran, et al. [14]. Using Large Eddy
Simulations (LES), Islam, et al. [15] simulated nanoparticle transport in lung models of
up to 17 generations and discussed the total deposition efficiency of particles across the
17 generations. Asgari, et al. [16] investigated aerosol microparticle deposition in a realistic
lung model of generations mouth to sixth generations (G6). The results showed that aerosol
deposition happens mainly in the upper lung airway.
The lung airways get larger as people grow to adult, and the shape of alveoli changes [17].
During postnatal growth, tidal and residual volumes, respiration rate, and respiratory
compliance rise, but respiratory resistance decreases [18]. This is due to the fact that infants
and children have immature and growing lung systems, higher physical activity levels,
and lower body weight than adults [19,20]. The airway structure and breathing habits
of children are different from adults [21]. When it comes to aerosol inhalation treatment,
infants and children constitute a distinct demographic of patients [22]. Xu and Yu [23]
established a theoretical model for predicting inhaled aerosol TD in the respiratory tracts of
children to adults and found that children had a higher deposition efficiency in the upper
airway region than adults.
Most medications were developed and approved based on adult trials. There is
relatively little information on the acceptability of different dose forms based on a chil-
dren. As a result, it is important to understand and improve particle TD in infants’ and
children’s lungs.
Lung airway branching pattern is different irrespective of age and sex. The lack of
high-resolution CT images also makes the geometry generation process complicated. As a
result, it is nearly impossible to generate an age-specific realistic lung model with consistent
similar branching patterns. Therefore, the age-specific micro-particles deposition into the
idealized lung airways model has been studied through CFD simulation [24,25].
The nanoscale aerosol particle TD as a drug delivery method into deep lung airways
is significant for treating lung diseases. Therefore, this study analyses the age-specific
different nanoparticles TD in an upper and lower (pulmonary) airway to ensure particles
go through the deep lung airways. In addition, it aims to understand the airflow character-
istics, wall shear effect, pressure drop, and particle deposition rate for infant, child, and
adult people through CFD simulations. The outcome of this investigation will provide
quantitative insight into how particle TD is affected by particle size and age.
2. Lung Model
2.1. Lung Geometry
According to the age categories used by the World Health Organization [26,27], we
consider 9-month, 6-year, and 30-year-old people as infants, children, and adults, respec-
tively. Weibel, et al. [11] developed planar and symmetric lung models of adult people.
However, the lung airway branching patterns for different ages of people are different.
Therefore, Xu and Yu [23] developed mathematical description of symmetric lung airways
structure for different ages people. We have calculated the details of the lung airways
diameter and length for infants, children, and adults (in Table 1) based on the mathematical
description [23]. The right-hand side of Figure 1 shows three-dimensional (3D) lung models
for upper (G0–G3) and lower generation (G12–G15) that are constructed using SolidWorks
software. The detailed geometric parameters of infant, child, and adult lung airways are
listed in Table 1.
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(G0–G3) 9 month old infant 6 year old child 30 year old adult
0 0.615 4.630 0.985 7.934 1.665 12.286
1 0.491 1.712 0.842 2.822 1.219 4.284
2 0.333 0.761 0.572 1.307 0.829 1.896
3 0.227 0.307 0.387 0.525 0.559 0.759
Lower airways
(G12–G15)
12 0.041 0.143 0.067 0.233 0.095 0.330
13 0.036 0.121 0.058 0.193 0.082 0.271
14 0.031 0.097 0.052 0.161 0.074 0.231
15 0.028 0.087 0.046 0.142 0.066 0.201
Figure 1. Symmetric models [11] (right) were used in this study to represent the human respiratory system provided by
Zhang, et al. [28] (Permission has been taken to use the left figure). The details of the geometric parameters of the lung
airways are presented in Table 1.
2.2. Mesh Generation
High resolution mesh in the lung airways has been developed and shown in Figure 2a.
In addition, Ten-layer smooth inflation is implemented near the wall to accurately predict
the wall boundary flow inside the lung airway, as illustrated in Figure 2b.
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Figure 2. An overview mesh generation for symmetric lung model. (a) The mesh resolution of lung airway and (b) the
refined inflation mesh near the airway wall.
3. Numerical Method
3.1. Airflow Model
The airflow in airways is solved using the software ANSYS FLUENT. The maximum
Reynolds numbers based on the airway diameter at G0 are 800, 1253, and 1281 for 9-month,
6-year, and 30-year ages, respectively. The flow for such small Reynolds numbers was

























where xi (i = 1, 2 and 3) are the Cartesian coordinates, ui is the fluid velocity in the
xi-direction, µ is the molecular viscosity, ρ is the air density, and p is the pressure.
The Navier-Stokes equations are solved using the second-order upwind momentum
SIMPLE scheme and the pressure-velocity coupling method. A constant inhalation flow
rate can be calculated by [24]:
Qin = 2fbVt (3)
where Vt is the tidal volume, which is defined as the amount of air that flows in and out
of the lungs during each respiratory cycle, and fb is the breathing frequency. Table 2 lists
the flow parameters used in this study. The velocity inlet and pressure outlet boundary
conditions are considered at the lung model’s inlet and outlet, respectively [29–33]. The
airway wall was considered to be stationary, and a non-slip boundary condition is used on
the wall surface [34–36]. The inhaled air flow rate is considered evenly distributed among
all the 2n bifurcations of generation G-n. As a result, the inlet air flow rate of each inlet of
G-n is Qne = Qin/2n, where Qin is the inlet flow rate at G0. Therefore, the inlet velocity of
each inlet boundary of G-n is calculated by:
u = Qne /An (4)
where An is the cross-sectional area of the inlet.
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Infant 33.82 47.68 3.22 1.806 0.098
Child 19.34 209.44 8.09 1.766 0.093
Adult 13.98 500 14 1.071 0.080
3.2. Particle Transport Model
The present particle TD model is a one-way coupling model that considers particle
movement in airflow but ignores particle effects on the airflow [6]. Initially, the airflow
field is simulated to obtain the converged flow solution. Then the particles are injected at
the inlet surface into the lung model. The discrete phase model (DPM) model based on the
Lagrangian approach is used in this study to model the motion of particles. The equation
of motion of each particle is expressed as [6]:
dupi
dt
= FDi + Fgi + FBi + FLi (5)
where upi is particle velocity in the xi-direction, FDi, Fgi, FBi, and FLi are the drag force,
gravitational force, Brownian force, and Saffman’s lift force per unit mass. The gravitational
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where, T = 300 K is the absolute fluid temperature, KB = 1.380649× 10−23 J/K is the Boltz-
mann constant, ν is the kinematic viscosity, and the Stokes-Cunningham slip correction
coefficient Cc is defined as
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In the simulations, 64,400 spherical particles with a uniform diameter and a density
of 1100 kg/m3 were injected randomly at the inlet surface at one time [36,39]. A ‘trap’
boundary condition is considered in the lung airways wall, and an escape condition is
considered at all outputs for particle deposition [28,40]. Due to the trap situation, the
coefficient of restitution is zero. Hence no bounce occurs when the particles meet the lung
airways surface. As a result, the particles are trapped on the surface and remain there.
Finally, the Tecplot software is used to visualize the deposition of particles in the lungs.
3.3. Deposition Efficiency Calculation
The deposition efficiency of the n-th generation, denoted by η, is the percentages of the
particles absorbed (trapped) in this generation of airways relative to the particles released
at the inlet surface, given by:
η =
Number of particles are trapped in a lung airway
Total number of particles released at the lung inlet
3.4. Grid Independence Study and Model Validation
3.4.1. Grid Dependency Test
Six meshes are used in the grid independency test, namely 64423 (Mesh-1), 116058
(Mesh-2), 192466 (Mesh-3), 290185 (Mesh-4), 364259 (Mesh-5), and 468164 (Mesh-6). The
smallest grid size of the densest mesh is 0.79 mm adjacent to the wall, and the mesh size
is proportional to the number of elements. The average velocity magnitude and the total
pressure are shown in Figure 3 (the different lines and sections of the lung are defined in
Figure 1). It was found that both velocity and pressure change with the increase of the grid
number from 64,423 to 468,164. Due to the increased grid number, the velocity distribution
trends are almost identical. The velocity difference between mesh-5 and mesh-6, especially,
is 0.012%. The average velocity and total pressure converge at a mesh of 364,259 elements
(Mesh-5), which is used to perform all the numerical calculations.
3.4.2. Model Validation
To validate the numerical method, Figure 4a,b show the CFD results of particle depo-
sition efficiency as a function of particle diameter for three Reynolds numbers (Re = 200,
500, and 1000) in the first and second bifurcation areas for G3–G5 model, respectively. The
deposition efficiency rate decreases exponentially with the increase of the particle diameter.
The variation trend of the deposition efficiency with dp agrees with those in other numerical
studies [7] and experimental data [41], demonstrating that the present model is accurate to
calculate the particle TD in the tracheobronchial airways of a lung.
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Figure 3. (a) Grid refinement/mesh-independent test for (a) velocity distribution as functions of grid number (average
velocity calculated at the selected line-1 in Figure 1), (b) velocity distribution as functions of grid number (average velocity
calculated at the selected line-2 in Figure 1), and (c) total pressure as functions of grid number at the flow rate 14 L/min
(Total pressure calculated at the selected Section-4 in Figure 1) for G0–G3 model for 30 year age.
Figure 4. Comparison between present simulation results at the generation G3–G5 model and results from literature [7,41]
(a) for the first bifurcation area; and (b) for the second bifurcation area.
Atmosphere 2021, 12, 1402 8 of 16
4. Results and Discussion
4.1. Airflow Characteristics
In this study, constant velocities at the inlets of the models of G0–G3 and G12–G15
are given based on Table 2. In many studies, the airflow velocity was considered to be
constant [42–44].
Figure 5 shows the velocity contours on the symmetric plane and five cross-sections
for generation G0–G3 of infants to adults. The five sections (AA′, BB′, CC′, DD′, and
EE′) are indicated on the symmetric plane. The velocity distribution in Section-1 for three
ages people is uniform at the central part. After the air enters the deep lung, the velocity
distribution in the rest of the section (Sections 2–5) is very non-uniform, as seen in Figure 5.
The maximum velocity is observed for 9 months lung model since the lung airways
diameter decreases compared to the 30-years age model. There is a qualitatively similar
fluctuation in velocity inside the generation G0–G3 compared to the lower generation
(G12–G15). According to our observations, lung airway flow rate influences patterns of
velocity magnitude.
4.2. Wall Shear Stress
Figure 6 quantitatively shows the average wall shear stress along with the inner wall
lung upper airways generation (G0–G3) on five sectional planes indicated in Figure 1.
Since flow resistance occurs at complicated lung geometry, the wall shear stress varies
considerably with each lung airway generation. With a contact inhaled air flow rate, the
wall shear stress decrease with the increase in age.
Figure 7 depicts the average static pressures in the generation G0–G3 lung airways
at various locations. For people of all ages, the highest pressure is shown in Section-1
(Figure 7). In addition to the reduction in velocity illustrated in Figure 5, the pressure
progressively lowers when airflow enters the deep lung. Due to friction from the inner
wall of the airways, the flow energy decreases when the airflow enters the deep lung.
The high velocity at the nine-months-old lung shown in Figure 7 requires high pressure
at the inlet to drive the flow. As a result, 56.35% pressure rise in the lung airways of
9-month-olds compared to 30-year-olds shown in Figure 7. Hence, inhaling air into the
lung for a 9-month-old is more complex than for a 30-year-old. The pressure at Section-5 is
significantly lower than at Section-1, owing to a drop in the volume flow rate. As a result
of the decrease in velocity, the low-pressure drop-in Section-5 was formed.
4.3. Particle Deposition
Figure 8 shows the effects of age on the particle deposition efficiency in G0–G3 and
G12–G15 models. The deposition efficiency of 5-nm particles is much higher than those of
the other three-particle diameters. The particle deposition efficiency decreases with the
increase of the particle size due to the weakening of the diffusion mechanism [45]. As seen
in Table 2, the flow velocity at G12–G15 is reduced significantly compared with G0–G3.
Since the diffusion mechanism is strong when the flow velocity is low [46], the deposition
efficiency of G12–G15 is 30% higher than that of G0–G3 (Figure 8). Hence, the particles
deposition efficiency is found to increase slightly with the increase of age. 2.13% more
particles were deposited in the 30-years-old lungs compared to the 9-months-old.
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Figure 5. Velocity contours at upper airways generation (G0–G3) defined in the above Figure: (a) 9 months, veloc-
ity = 1.806 m/s, (b) 6 years age, velocity = 1.766 m/s, and (c) 30 years age, velocity = 1.071 m/s.
Atmosphere 2021, 12, 1402 10 of 16
Figure 6. Averaged wall shear stress at a different section of the lung defined in Figure 1 for infant,
child and adult ages.
Figure 7. Pressure at a different section of the lung defined in Figure 1 for infant, child, and adult ages.
Figure 8. Particle deposition efficiencies of the lung are defined in Figure 1. (a) Upper airways (G0–G3) and (b) lower
airways (G12–G15).
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Figure 9 shows the visualization of the particle distribution of different sized particles
at generation G12–G15 of 30-year age. The calculated total particle deposition efficiencies
of G12–G15 are 99.42%, 46.80%, 27.45%, and 3.33% for 5 nm, 50 nm, 100 nm, and 500 nm
particles, respectively. It can be found that 5 nm particles are more evenly distributed in
each lung airways generation compared to the larger particles (500 nm). Hence, 500 nm
size particle is observed to have less deposition than smaller diameters since the diffu-
sion mechanism weakens with the increase of particle diameter. The Brownian diffusion
mechanism results in more particles being deposited due to the low airflow velocity [7,14].
Figure 9. Visualization of particle deposition for the 30 years age for generation G12–G15 of the lung defined in Figure 1.
(a) dp = 5 nm, (b) dp = 50 nm, (c) dp = 100 nm, and (d) dp = 500 nm at a flow rate of 14 L/min.
How the ages and particle size affect deposition rates at individual generations in
the upper lung airways (G0–G3) can be examined by the bar charts shown in Figure 10.
The locations of different generations are defined in Figure 1. Most of the particles are
deposited at generation G0 for all the studied ages and particle diameters. Around 34.88%,
35.67%, and 37.72% of 5 nm particles are deposited at generation G0 for 9-month, 6-years
and 30-years of age, respectively (Figure 10a). For the three ages, the lowest deposition
efficiency occurs at the largest particle size of 500 nm and it decreases with the increase of
generation number. Figure 4 demonstrates that the deposition efficiency in generations
G3–G5 increases with the reduction of either the Reynolds number or flow velocity. The de-
Atmosphere 2021, 12, 1402 12 of 16
crease of the flow velocity decreases with age results in an increase in deposition efficiency
in G0–G3 in Figure 10.
Figure 10. Different size particle deposition efficiencies at upper airways generation (G0–G3) of the lung are defined in
Figure 1. (a) dp = 5 nm, (b) dp = 50 nm, (c) dp = 100 nm, and (d) dp = 500 nm.
Figure 11 shows the deposition efficiency at individual generations in the lower lung
airways (G12–G15) for the three ages. The effect of age on the deposition efficiency of
G12–G15 is the same as that for G0–G3. At nine-months of age, the deposition efficiencies
of lower generations (G15) are smaller compared to the adult age. The deposition efficiency
in G12–G15 for all the diameters was considerably reduced compared to that in G0–G3.
At 9-month age, 15.61%, 14.05%, 12.71%, and 1.57% of 50 nm particles are deposited at
the generation G12, G13, G14, and G15, respectively (Figure 11b). It is also observed that
8.02% at G12, 7.54% at G13, 6.37% at G14, and 1.16% at G15, more particles were deposited
of 100 nm compared to 500 nm for six-year-olds (Figure 11c,d). The particles deposition
efficiency decreases with increases the particles size (Figure 11a).
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Figure 11. Different size particle deposition efficiencies at lower airways generation (G12–G15) of the lung are defined in
Figure 1. (a) dp = 5 nm, (b) dp = 50 nm, (c) dp = 100 nm, and (d) dp = 500 nm.
Numerical calculations were conducted based on age-specific lung models in the
upper and lower airways. The flow characteristics and pressures differ due to age-related
differences in lung geometries that have varied diameters. Due to lung aging and flow rate,
the diameter reduction influenced the velocity magnitude for infant to adult ages. Hence,
the present study has several contributions: (1) we have considered the three age groups
(infant, child, and adult) to identify the effects of age on particle TD; (2) we consider the
nanoparticle TD through diffusion mechanism both in upper (G0–G3) and lower (G12–G15)
airways; (3) we consider the different airflow velocity in different airway generations.
4.4. Limitations of the Study
There are some limitations in this study that should be addressed in future studies.
Firstly, only an inhalation flow condition was considered in the simulation of particle TD.
Secondly, deformation of the lung wall was not considered in this study. Thirdly, we have
used symmetric and planner lung airways models due to the lack of high-resolution CT
images for age-specific realistic lung geometry. However, despite the constraints of lung
geometry used in this study, our current investigation of airflow characteristics and particle
deposition patterns can accurately predict [42,47]. Thus, the results of this work could
improve a basic understanding of airflow properties and nanoparticle TD in the human
lung airways related to lung ageing.
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5. Conclusions
We investigated nanoparticle TD in the upper (G0–G3) and lower (G12–G15) airways
of the infant to adult ages. The variation of the airway geometry and the flow velocity with
age has been considered. The deposition efficiency of particles is found to be significantly
affected by lung airways reduction. The effects of age and particle diameter on the airflow
and particle TD are summarized as follows.
• The average wall shear stress is decreased with an increase of age. The pressure of
generation G0 to G3 of a 9-month-old lung is 56.35% higher than the 30-year-old lung
due to the inhalation flow rate.
• 30% more particles are deposited in the lower airways (G12–G15) than in the upper
airways (G0–G3).
• 60.32%, 61.31%, and 61.75% 5-nm particles are deposited in the generation G12 for
9-month, 6-year, and 30-year ages, respectively, which indicates that the number of
particle deposition increases with increased age.
• A high percentage of the 5-nm particles (over 95%) entering G12 can be deposited in
the deep lung airways (G12–G15). As the particle size is increased to 500 nm, only
3% of the particles are deposited in the G12–G15 lung airways. The above finding
indicates that particles must have a small diameter to increase the deposition in the
deep lung airways.
• The numerical study showed that deposition efficiency is significantly affected by
lung airways reduction. Most of the particles are deposited in the 30-year-old lung
than 9-month-old lung in the lower generations compared to the upper generation.
Therefore, our results further investigate that correctly choosing particles size as
targeted drug-aerosol delivery size based on age.
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